Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Fulcrum Therapeutics (FULC) Asset Utilization Ratio (2020 - 2025)

Fulcrum Therapeutics (FULC) has disclosed Asset Utilization Ratio for 6 consecutive years, with 0.32 as the latest value for Q1 2025.

  • On a quarterly basis, Asset Utilization Ratio rose 3004.4% to 0.32 in Q1 2025 year-over-year; TTM through Mar 2025 was 0.32, a 3004.4% increase, with the full-year FY2024 number at 0.31, up 2564.82% from a year prior.
  • Asset Utilization Ratio was 0.32 for Q1 2025 at Fulcrum Therapeutics, up from 0.3 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.32 in Q1 2025 to a low of 0.01 in Q3 2023.
  • A 5-year average of 0.11 and a median of 0.07 in 2022 define the central range for Asset Utilization Ratio.
  • Peak YoY movement for Asset Utilization Ratio: tumbled 85.94% in 2023, then surged 3064.27% in 2024.
  • Fulcrum Therapeutics' Asset Utilization Ratio stood at 0.08 in 2021, then crashed by 65.79% to 0.03 in 2022, then tumbled by 60.89% to 0.01 in 2023, then skyrocketed by 2735.39% to 0.3 in 2024, then rose by 7.22% to 0.32 in 2025.
  • Per Business Quant, the three most recent readings for FULC's Asset Utilization Ratio are 0.32 (Q1 2025), 0.3 (Q4 2024), and 0.28 (Q3 2024).